Dosage |
25 mg/wk i.m., if remission is achieved reduce to 15 i.m. (or s.c.) |
Indications |
Maintenance, chronically active disease, steroid-refractory and steroid-dependency, fistulae |
Important side effects |
Nausea, abdominal pain, diarrhea, stomatitis; hepatitis, liver fibrosis; hypersensivity pneumonitis |
Monitoring |
Liver function and full blood count monthly for the first two months, if normal then every two months throughout therapy |
Pregnancy |
Strictly prohibited |
Comments |
Entire therapeutic efficacy is observed mostly after 2-4 mo; consider folic acid supplementation with 2.5-5 mg/d; ensure adequate birth control; allow 3 mo time before pregnancy or conceiving |